Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
GrantShare Option C (right to buy) · Derivative | 7,150 | Not disclosed Strike: $27.85 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 10 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,150 Underlying: Class C Common Shares · 7,150 shares Expires 2027-06-21 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
Disposition to issuerShare Option C (right to buy) · Derivative | 7,150 | Not disclosed Strike: $27.85 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 9 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 7,150 shares Expires 2027-06-21 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
GrantShare Option C (right to buy) · Derivative | 5,840 | Not disclosed Strike: $29.64 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 8 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,840 Underlying: Class C Common Shares · 5,840 shares Expires 2026-06-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
Disposition to issuerShare Option C (right to buy) · Derivative | 5,840 | Not disclosed Strike: $29.64 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 7 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 5,840 shares Expires 2026-06-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
GrantShare Option A (right to buy) · Derivative | 4,412 | Not disclosed Strike: $30.14 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 6 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,412 Underlying: Class A Common Shares · 4,412 shares Expires 2028-06-12 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
Disposition to issuerShare Option A (right to buy) · Derivative | 4,412 | Not disclosed Strike: $30.14 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 5 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 4,412 shares Expires 2028-06-12 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
GrantShare Option A (right to buy) · Derivative | 3,575 | Not disclosed Strike: $28.83 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 4 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,575 Underlying: Class A Common Shares · 3,575 shares Expires 2027-06-21 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
Disposition to issuerShare Option A (right to buy) · Derivative | 3,575 | Not disclosed Strike: $28.83 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 3 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 3,575 shares Expires 2027-06-21 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
GrantShare Option A (right to buy) · Derivative | 2,920 | Not disclosed Strike: $30.47 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 2 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,920 Underlying: Class A Common Shares · 2,920 shares Expires 2026-06-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment |
COLE ANDREWDirector
|
Disposition to issuerShare Option A (right to buy) · Derivative | 2,920 | Not disclosed Strike: $30.47 | Not disclosed |
DisclosureSEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 1 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 2,920 shares Expires 2026-06-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
GrantShare Option C (right to buy) · Derivative | 129,974 | Not disclosed Strike: $28.94 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 10 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,974 Underlying: Class C Ordinary Shares · 129,974 shares Expires 2028-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
Disposition to issuerShare Option C (right to buy) · Derivative | 129,974 | Not disclosed Strike: $28.94 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 9 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Ordinary Shares · 129,974 shares Expires 2025-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
GrantShare Option C (right to buy) · Derivative | 64,946 | Not disclosed Strike: $34.80 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 8 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,946 Underlying: Class C Ordinary Shares · 64,946 shares Expires 2027-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
Disposition to issuerShare Option C (right to buy) · Derivative | 64,946 | Not disclosed Strike: $34.80 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 7 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Ordinary Shares · 64,946 shares Expires 2024-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
GrantShare Option C (right to buy) · Derivative | 60,518 | Not disclosed Strike: $31.65 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 6 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,518 Underlying: Class C Ordinary Shares · 60,518 shares Expires 2026-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
Disposition to issuerShare Option C (right to buy) · Derivative | 60,518 | Not disclosed Strike: $31.65 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 5 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Ordinary Shares · 60,518 shares Expires 2023-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
GrantShare Option A (right to buy) · Derivative | 32,473 | Not disclosed Strike: $35.69 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 4 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,473 Underlying: Class A Ordinary Shares · 32,473 shares Expires 2027-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
Disposition to issuerShare Option A (right to buy) · Derivative | 32,473 | Not disclosed Strike: $35.69 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 3 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Shares · 32,473 shares Expires 2024-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
GrantShare Option A (right to buy) · Derivative | 30,259 | Not disclosed Strike: $32.81 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 2 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,259 Underlying: Class A Ordinary Shares · 30,259 shares Expires 2026-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:03 UTC |
MALONE JOHN CDirector · 10% owner
|
Disposition to issuerShare Option A (right to buy) · Derivative | 30,259 | Not disclosed Strike: $32.81 | Not disclosed |
DisclosureSEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 1 MALONE JOHN C · CIK 0000937797 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Shares · 30,259 shares Expires 2023-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:52 UTC |
WARGO J DAVIDDirector
|
GrantClass C Share Fund Units · Derivative | 916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000108 · wf-form4_168064513050389.xml · derivative · entry 5 WARGO J DAVID · CIK 0001082013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,474 Underlying: Class C Ordinary Shares · 916 shares Expires not disclosed F3 · derivative.exercise_price: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan. F4 · price: The share fund units represent the deferral of shares for a portion of the fees paid to the Reporting Person for his services as a director. The number of share fund units acquired is based on the closing prices of the Class A and Class C ordinary shares on March 31, 2023, with the value of any fractional shares deferred in cash. F3 · derivative.exercise_date: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan. F3 · derivative.expiration_date: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:52 UTC |
WARGO J DAVIDDirector
|
GrantClass A Share Fund Units · Derivative | 458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000108 · wf-form4_168064513050389.xml · derivative · entry 4 WARGO J DAVID · CIK 0001082013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,737 Underlying: Class A Ordinary Shares · 458 shares Expires not disclosed F3 · derivative.exercise_price: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan. F4 · price: The share fund units represent the deferral of shares for a portion of the fees paid to the Reporting Person for his services as a director. The number of share fund units acquired is based on the closing prices of the Class A and Class C ordinary shares on March 31, 2023, with the value of any fractional shares deferred in cash. F3 · derivative.exercise_date: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan. F3 · derivative.expiration_date: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:52 UTC |
WARGO J DAVIDDirector
|
GrantClass C Ordinary Shares | 140 | $20.38 | $2,853.20 |
DisclosureSEC source: 0001570585-23-000108 · wf-form4_168064513050389.xml · nonDerivative · entry 2 WARGO J DAVID · CIK 0001082013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,288 F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:52 UTC |
WARGO J DAVIDDirector
|
GrantClass A Ordinary Shares | 70 | $19.50 | $1,365.00 |
DisclosureSEC source: 0001570585-23-000108 · wf-form4_168064513050389.xml · nonDerivative · entry 1 WARGO J DAVID · CIK 0001082013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,623 F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:52 UTC |
COLE ANDREWDirector
|
GrantClass C Ordinary Shares | 539 | $20.38 | $10,984.82 |
DisclosureSEC source: 0001570585-23-000107 · wf-form4_168064511212091.xml · nonDerivative · entry 2 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,437 F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:52 UTC |
COLE ANDREWDirector
|
GrantClass A Ordinary Shares | 269 | $19.50 | $5,245.50 |
DisclosureSEC source: 0001570585-23-000107 · wf-form4_168064511212091.xml · nonDerivative · entry 1 COLE ANDREW · CIK 0001439731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,374 F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023. Read SEC document |
| March 30, 2023 Filed Mar 30, 2023 21:30 UTC |
HALL BRYAN HEVP, Gen Counsel & Secretary
|
SaleClass C Ordinary Shares | 6,000 | $20.04 | $120,248.40 |
DisclosureSEC source: 0001570585-23-000099 · wf-form4_168021179868817.xml · nonDerivative · entry 2 HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,497 Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 21:30 UTC |
HALL BRYAN HEVP, Gen Counsel & Secretary
|
SaleClass C Ordinary Shares | 10,000 | $19.77 | $197,673.00 |
DisclosureSEC source: 0001570585-23-000099 · wf-form4_168021179868817.xml · nonDerivative · entry 1 HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,497 Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:37 UTC |
BRACKEN CHARLES H REVP & CFO
|
GrantShare Appreciation Rights C · Derivative | 288,350 | $0.00 Strike: $19.38 | $0.00 |
DisclosureSEC source: 0001570585-23-000086 · wf-form4_168003942909579.xml · derivative · entry 4 BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,350 Underlying: Class C Ordinary Shares · 288,350 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:37 UTC |
BRACKEN CHARLES H REVP & CFO
|
GrantShare Appreciation Rights A · Derivative | 144,175 | $0.00 Strike: $18.52 | $0.00 |
DisclosureSEC source: 0001570585-23-000086 · wf-form4_168003942909579.xml · derivative · entry 3 BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,175 Underlying: Class A Ordinary Shares · 144,175 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:37 UTC |
BRACKEN CHARLES H REVP & CFO
|
GrantRestricted Share Units C · Derivative | 106,840 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000086 · wf-form4_168003942909579.xml · derivative · entry 2 BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,840 Underlying: Class C Ordinary Shares · 106,840 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:37 UTC |
BRACKEN CHARLES H REVP & CFO
|
GrantRestricted Share Units A · Derivative | 53,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000086 · wf-form4_168003942909579.xml · derivative · entry 1 BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,420 Underlying: Class A Ordinary Shares · 53,420 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:37 UTC |
FRIES MICHAEL TDirector · President & CEO
|
GrantShare Appreciation Rights C · Derivative | 1,504,272 | $0.00 Strike: $19.38 | $0.00 |
DisclosureSEC source: 0001570585-23-000087 · wf-form4_168003945329936.xml · derivative · entry 2 FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,504,272 Underlying: Class C Ordinary Shares · 1,504,272 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:37 UTC |
FRIES MICHAEL TDirector · President & CEO
|
GrantRestricted Share Units C · Derivative | 556,566 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000087 · wf-form4_168003945329936.xml · derivative · entry 1 FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 556,566 Underlying: Class C Ordinary Shares · 556,566 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:39 UTC |
Waldron JasonSVP & CAO
|
GrantShare Appreciation Rights C · Derivative | 92,272 | $0.00 Strike: $19.38 | $0.00 |
DisclosureSEC source: 0001570585-23-000091 · wf-form4_168003954554918.xml · derivative · entry 4 Waldron Jason · CIK 0001693396 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,272 Underlying: Class C Ordinary Shares · 92,272 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:39 UTC |
Waldron JasonSVP & CAO
|
GrantShare Appreciation Rights A · Derivative | 46,136 | $0.00 Strike: $18.52 | $0.00 |
DisclosureSEC source: 0001570585-23-000091 · wf-form4_168003954554918.xml · derivative · entry 3 Waldron Jason · CIK 0001693396 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,136 Underlying: Class A Ordinary Shares · 46,136 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:39 UTC |
Waldron JasonSVP & CAO
|
GrantRestricted Share Units C · Derivative | 34,188 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000091 · wf-form4_168003954554918.xml · derivative · entry 2 Waldron Jason · CIK 0001693396 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,188 Underlying: Class C Ordinary Shares · 34,188 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:39 UTC |
Waldron JasonSVP & CAO
|
GrantRestricted Share Units A · Derivative | 17,094 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000091 · wf-form4_168003954554918.xml · derivative · entry 1 Waldron Jason · CIK 0001693396 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,094 Underlying: Class A Ordinary Shares · 17,094 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:38 UTC |
HALL BRYAN HEVP, Gen Counsel & Secretary
|
GrantShare Appreciation Rights C · Derivative | 196,078 | $0.00 Strike: $19.38 | $0.00 |
DisclosureSEC source: 0001570585-23-000088 · wf-form4_168003947803598.xml · derivative · entry 4 HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,078 Underlying: Class C Ordinary Shares · 196,078 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:38 UTC |
HALL BRYAN HEVP, Gen Counsel & Secretary
|
GrantShare Appreciation Rights A · Derivative | 98,039 | $0.00 Strike: $18.52 | $0.00 |
DisclosureSEC source: 0001570585-23-000088 · wf-form4_168003947803598.xml · derivative · entry 3 HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,039 Underlying: Class A Ordinary Shares · 98,039 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:38 UTC |
HALL BRYAN HEVP, Gen Counsel & Secretary
|
GrantRestricted Share Units C · Derivative | 72,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000088 · wf-form4_168003947803598.xml · derivative · entry 2 HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,652 Underlying: Class C Ordinary Shares · 72,652 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:38 UTC |
HALL BRYAN HEVP, Gen Counsel & Secretary
|
GrantRestricted Share Units A · Derivative | 36,326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000088 · wf-form4_168003947803598.xml · derivative · entry 1 HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,326 Underlying: Class A Ordinary Shares · 36,326 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:38 UTC |
Rodriguez EnriqueEVP, Chief Technology Officer
|
GrantShare Appreciation Rights C · Derivative | 244,520 | $0.00 Strike: $19.38 | $0.00 |
DisclosureSEC source: 0001570585-23-000089 · wf-form4_168003950796599.xml · derivative · entry 4 Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,520 Underlying: Class C Ordinary Shares · 244,520 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:38 UTC |
Rodriguez EnriqueEVP, Chief Technology Officer
|
GrantShare Appreciation Rights A · Derivative | 122,260 | $0.00 Strike: $18.52 | $0.00 |
DisclosureSEC source: 0001570585-23-000089 · wf-form4_168003950796599.xml · derivative · entry 3 Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,260 Underlying: Class A Ordinary Shares · 122,260 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:38 UTC |
Rodriguez EnriqueEVP, Chief Technology Officer
|
GrantRestricted Share Units C · Derivative | 90,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000089 · wf-form4_168003950796599.xml · derivative · entry 2 Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,600 Underlying: Class C Ordinary Shares · 90,600 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:38 UTC |
Rodriguez EnriqueEVP, Chief Technology Officer
|
GrantRestricted Share Units A · Derivative | 45,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000089 · wf-form4_168003950796599.xml · derivative · entry 1 Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,300 Underlying: Class A Ordinary Shares · 45,300 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:39 UTC |
Salvato AndreaEVP, CHIEF DEVELOPMENT OFFICER
|
GrantShare Appreciation Rights C · Derivative | 276,816 | $0.00 Strike: $19.38 | $0.00 |
DisclosureSEC source: 0001570585-23-000090 · wf-form4_168003952675185.xml · derivative · entry 4 Salvato Andrea · CIK 0001778743 · EVP, CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,816 Underlying: Class C Ordinary Shares · 276,816 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:39 UTC |
Salvato AndreaEVP, CHIEF DEVELOPMENT OFFICER
|
GrantShare Appreciation Rights A · Derivative | 138,408 | $0.00 Strike: $18.52 | $0.00 |
DisclosureSEC source: 0001570585-23-000090 · wf-form4_168003952675185.xml · derivative · entry 3 Salvato Andrea · CIK 0001778743 · EVP, CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,408 Underlying: Class A Ordinary Shares · 138,408 shares Expires 2033-03-24 F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:39 UTC |
Salvato AndreaEVP, CHIEF DEVELOPMENT OFFICER
|
GrantRestricted Share Units C · Derivative | 102,566 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000090 · wf-form4_168003952675185.xml · derivative · entry 2 Salvato Andrea · CIK 0001778743 · EVP, CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,566 Underlying: Class C Ordinary Shares · 102,566 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:39 UTC |
Salvato AndreaEVP, CHIEF DEVELOPMENT OFFICER
|
GrantRestricted Share Units A · Derivative | 51,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001570585-23-000090 · wf-form4_168003952675185.xml · derivative · entry 1 Salvato Andrea · CIK 0001778743 · EVP, CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,283 Underlying: Class A Ordinary Shares · 51,283 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.